Medtronic’s PulseSelect PFA System Gets FDA Nod, Revolutionizing Atrial Fibrillation Treatment in US
The FDA approved Medtronic plc's (NYSE: MDT) PulseSelect Pulsed Field Ablation (PFA) System for the treatment of both paroxysmal and persistent atrial fibrillation (AF), an irregular and often